Clinical Trial Update: A Clinical Trial to Evaluate Safety, Tolerance and Pharmacokinetics of JX11502MA Capsule in Patients With Schizophrenia. [Phase 1, Phase 2]

View source ↗

Summary

A clinical trial evaluating safety, tolerance, and pharmacokinetics of JX11502MA capsule in schizophrenia has completed Phase 1 and Phase 2.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Schizophrenia

Drugs mentioned

• JX11502MA capsule

Snippet

Sponsor: Zhejiang Jingxin Pharmaceutical Co., Ltd. | Conditions: Schizophrenia | Phase 1, Phase 2 | Status: COMPLETED